Genericart Metoprolol Succinate+Hydrochlorothiazide 25mg /12.5mg Tablet ER
Marketer
Swast Aushadhi Seva Generic Medicine Store
Salt Composition
Metoprolol Succinate (23.75mg) + Hydrochlorothiazide (12.5mg)
Overview Genericart Metoprolol Succinate+Hydrochlorothiazide 25mg /12.5mg Tablet ER
Metoprolol Succinate and Hydrochlorothiazide 25mg/12.5mg extended-release tablets (Genericart) are prescribed for managing hypertension. This combination therapy effectively controls blood pressure when monotherapy proves insufficient. It also contributes to lowering the risk of future strokes and heart attacks, improving survival rates in heart attack patients when initiated promptly. Administer this medication once daily, preferably in the morning, with or without food, to minimize nocturnal urination. Continue treatment as directed by your physician; discontinuing prematurely, even if feeling well, is inadvisable as hypertension often presents asymptomatically and could lead to worsening of your condition. Lifestyle modifications, including regular exercise, weight management, and a balanced diet, further enhance blood pressure control. Always follow your doctor's instructions. Common side effects include nausea, constipation, diarrhea, and fatigue. Report any persistent, worsening, or troublesome side effects immediately. Maintain adequate hydration to mitigate potential symptoms such as muscle weakness, dry mouth, and thirst. Dizziness or headache, potentially indicative of low blood pressure, may occur; rise slowly from a seated or lying position and avoid driving if affected. Inform your doctor about any pre-existing liver or kidney conditions, and pregnant or breastfeeding women should seek medical advice before commencing treatment. Disclose all current medications, particularly those for heart conditions or hypertension. Regular monitoring of blood pressure, kidney function, blood sugar, and electrolyte levels (potassium and magnesium) is essential to optimize treatment efficacy and safety.
Primary Ingredients of Genericart Metoprolol Succinate+Hydrochlorothiazide 25mg /12.5mg Tablet ER
The provided text is "undefined," therefore no rewriting is possible.
Uses of Genericart Metoprolol Succinate+Hydrochlorothiazide 25mg /12.5mg Tablet ER
Elevated blood pressure
Major Benefits of Genericart Metoprolol Succinate+Hydrochlorothiazide 25mg /12.5mg Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Genericart Metoprolol Succinate+Hydrochlorothiazide 25mg/12.5mg Extended-Release tablet whole; avoid chewing, crushing, or breaking it. This medicine can be taken with or without food, although consistent timing is recommended.
Common Side effects of Genericart Metoprolol Succinate+Hydrochlorothiazide 25mg /12.5mg Tablet ER:
- Fatigue
- Nasopharyngitis (inflammation of the throat and nasal passages)
How to use Genericart Metoprolol Succinate+Hydrochlorothiazide 25mg /12.5mg Tablet ER:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Genericart Metoprolol Succinate+Hydrochlorothiazide 25mg/12.5mg Extended-Release tablet whole; avoid chewing, crushing, or breaking it. This medication can be taken with or without food, although consistent timing is recommended.
How Genericart Metoprolol Succinate+Hydrochlorothiazide 25mg /12.5mg Tablet ER works:
Genericart's extended-release tablet, combining 25mg Metoprolol Succinate and 12.5mg Hydrochlorothiazide, offers a dual approach to hypertension management. Metoprolol Succinate, a beta-blocker, acts directly on the heart, slowing its rhythm and boosting its pumping efficiency. Hydrochlorothiazide, a diuretic, reduces blood pressure by eliminating excess fluid and electrolytes, while concurrently promoting vasodilation and improved circulation.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use with Genericart Metoprolol Succinate/Hydrochlorothiazide 25mg/12.5mg extended-release tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The extended-release combination of metoprolol succinate and hydrochlorothiazide (25mg/12.5mg) from Genericart may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing this medication. Seek medical advice before use.
Breast feedingSAFE IF PRESCRIBED
The extended-release combination of metoprolol succinate and hydrochlorothiazide (25mg/12.5mg) marketed as Genericart is likely safe for breastfeeding mothers. Available data from human studies indicate minimal risk to the infant.
DrivingUNSAFE
Extended-release Metoprolol Succinate and Hydrochlorothiazide tablets (Genericart, 25mg/12.5mg) can cause drowsiness, blurred vision, and dizziness. Refrain from driving if experiencing these effects.
KidneyCAUTION
Extended-release metoprolol succinate/hydrochlorothiazide 25mg/12.5mg tablets require careful administration in individuals with advanced renal impairment. Dosage modification may be necessary. Physician consultation is advised. This medication is generally unsuitable for patients exhibiting severe kidney disease.
LiverCAUTION
Patients with liver impairment should use extended-release metoprolol succinate/hydrochlorothiazide 25mg/12.5mg tablets cautiously. Dosage modification may be necessary; physician consultation is advised.
What if you forget to take Genericart Metoprolol Succinate+Hydrochlorothiazide 25mg /12.5mg Tablet ER :
Should you forget a dose of your Genericart Metoprolol Succinate and Hydrochlorothiazide 25mg/12.5mg extended-release tablet, take it immediately. If your next dose is imminent, however, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Genericart Metoprolol Succinate+Hydrochlorothiazide 25mg /12.5mg Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Heart |
3,018 People bought this recently